Senate Bill Proposal Delays Hemp Restrictions, Extending CBD Market Access
Event summary
- Senate spending bill released August 2 delays federal hemp restrictions from November 12 to December 11.
- Proposal preserves access to full-spectrum CBD and naturally derived hemp products during extension.
- House previously passed continuing resolution without hemp provisions, requiring reconciliation.
- cbdMD assesses its core portfolio falls within protected category of naturally derived hemp products.
The big picture
This Senate proposal represents the most significant legislative progress for the hemp industry since the 2018 Farm Bill. The delay in restrictions provides temporary relief but underscores ongoing regulatory uncertainty that could impact market stability. cbdMD and other naturally derived CBD producers now have a window to advocate for permanent, sensible regulations while maintaining business continuity.
What we're watching
- Legislative Uncertainty
- Whether the Senate's hemp provisions survive House reconciliation and presidential approval.
- Regulatory Framework
- How Congress will address permanent rules for hemp-derived products by December 11 deadline.
- Industry Positioning
- The pace at which cbdMD and peers can influence long-term regulatory standards.